Human ERBB2 ELISA Kit

Introduction

The Human ERBB2 ELISA Kit is a highly sensitive and specific assay designed for the quantitative measurement of Human ERBB2 protein levels in various biological samples. This kit is a valuable tool for both basic research and clinical applications, as it provides accurate and reliable results in a simple and cost-effective manner.

Structure of ERBB2 Protein

ERBB2, also known as HER2 or Neu, is a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. It is a transmembrane protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains four subdomains (I-IV) that are involved in ligand binding, while the intracellular domain contains the tyrosine kinase catalytic domain.

Activity of ERBB2 Protein

ERBB2 is a key regulator of cell growth and differentiation. Upon binding of its ligand, such as epidermal growth factor (EGF), ERBB2 forms homodimers or heterodimers with other members of the EGFR family, leading to the activation of its tyrosine kinase activity. This results in the phosphorylation of specific tyrosine residues on the intracellular domain of ERBB2, which then serves as docking sites for downstream signaling molecules. These signaling pathways are involved in various cellular processes, including cell proliferation, survival, and differentiation.

Application of ERBB2 ELISA Kit Therapeutic Target

ERBB2 is a well-known therapeutic target in various types of cancer, particularly breast cancer. It is overexpressed in approximately 20-30% of breast cancer cases and is associated with a more aggressive form of the disease. The Human ERBB2 ELISA Kit can be used to accurately measure the levels of ERBB2 in patient samples, providing valuable information for the selection of appropriate treatment options. In addition, the kit can also be used to monitor the response to targeted therapies that specifically inhibit ERBB2 activity, such as trastuzumab.

Research Use

In addition to its clinical applications, the Human ERBB2 ELISA Kit is also widely used in basic research. It allows for the quantification of ERBB2 levels in various biological samples, including cell lysates, tissue homogenates, and serum/plasma. This enables researchers to study the role of ERBB2 in different cellular processes and disease states. For example, the kit has been used to investigate the mechanisms of ERBB2-driven tumorigenesis and to identify potential therapeutic targets for ERBB2-positive cancers.

Other Applications Apart from breast

cancer, ERBB2 is also implicated in the development and progression of other types of cancer, such as ovarian, gastric, and lung cancer. The Human ERBB2 ELISA Kit can be used to measure ERBB2 levels in these cancers as well, providing valuable insights into their biology and potential therapeutic options. Moreover, the kit can also be used to study the expression of ERBB2 in non-cancerous conditions, such as cardiovascular diseases and neurological disorders.

Conclusion

In summary, the Human ERBB2 ELISA Kit is a highly sensitive and specific assay that allows for the accurate measurement of ERBB2 levels in various biological samples. Its application as a therapeutic target and research tool has greatly contributed to our understanding of the role of ERBB2 in disease and has the potential to lead to the development of effective treatments. With its ease of use and cost-effectiveness, this kit is a valuable asset for both basic research and clinical applications.